Banner Location Image
Request Free Consultation
Posted on May 30, 2012

FDA to Decide on Approval of Genetically Modified Mosquito Release

A good majority of people out there have probably been plagued by mosquitoes and their bites at some point, and numerous persons are probably resigned to the fact that mosquito bites are simply a fact of life.  But this might not be the case if a team of scientists has their way. A British biotech… read more

Read Article
Posted on May 24, 2012

FDA Panel Advises Against Xarelto Approval

Going against the opinion of one of the Food and Drug Administration’s drug reviewers, an advisory panel opted to vote against the approval of a potential blood thinner medication. The drug in question is called Xarelto (rivaroxaban).  Already on the market for a couple other conditions, its maker was hoping to gain approval to to… read more

Read Article
Posted on May 22, 2012

FDA Drug Reviewers Advise Against Approval of Pfizer’s Tafamadis

A pill designed by Pfizer to help those with a certain deadly medical condition is facing an advisory panel composed of outside experts on Thursday, and in the lead-up, the pill already has one strike against it. Drug reviewers from the Food and Drug Administration have advised not approving the drug known as tafamidis.  That’s… read more

Read Article
Posted on May 21, 2012

FDA Could Approve Xarelto Despite Internal Bleeding Risk

A drug that could help prevent blood clots in certain persons is going to be reviewed on Wednesday, and even though the Food and Drug Administration is cautiously optimistic about its approval, officials still have worries. Johnson & Johnson is the maker of the drug, which is called Xarelto.  The drug is already on the… read more

Read Article
Posted on April 23, 2012

FDA Proud of Post Approval Drug Safety Enforcement Efforts

The Food and Drug Administration is touting its ability to police drugs even after they’ve been approved. On Saturday, the organization said that the same amount of resources are spent making sure that existing drugs are safe as are spent in the pre-approval stage of a drug’s life.  The statement came following critics’ remarks that… read more

Read Article
Posted on April 16, 2012

Cancer Drugs Seized After Circumventing FDA Approval Process

United States Marshals seized a number of supposed cancer curing drugs from a plant in Bogard, Missouri. The seizure was initiated following a request by the Food and Drug Administration, who investigated the plant in January following a complaint from a consumer.  The manufacturer in question, Notions-N-Things Distribution, was responsible for marketing drugs that purported… read more

Read Article
Posted on December 27, 2011

HIV Drug Isentress Gains Expanded FDA Approval

According to news sources, the drug Isentress (raitegravir) has been given expanded approval by The Food and Drug Administration to begin being used by those between 2-18 years of age. The drug was first approved for adult usage back in October 2007 under the agency’s accelerated approval program, which aims to make the introduction of… read more

Read Article
Posted on December 16, 2011

Children Mechanical Cardiac Assist Device Approved By FDA

According to news sources, the Food and Drug Administration has recently approved a medical device to help children suffering from heart failure that will reportedly to stay alive while a heart transplant donor can be found. The device us called EXCOR Pediatric System and was developed by Berlin Heart for the purpose of fitting the… read more

Read Article
Posted on December 15, 2011

FDA To Allow Marketing For Bleeding Skull Detection Tool

According to news sources, the Food and Drug Administration has just given approval to InfraScan Inc. of Philadelphia to begin marketing the first non invasive hand-held device to be utilized in detecting bleeding skulls. The device, named the Infrascanner Model 1000, uses near-infrared spectroscopy to help identify bleeding in the skull. Health care providers will… read more

Read Article
Posted on December 7, 2011

FDA Approves Drug To Treat Rare Disorder

According to news sources, The Food and Drug Administration has recently approved the first drug aimed at treating a rare kind of bone marrow disorder that causes a build up of red blood cells in the bone marrow. The drug comes in the form of a pill and is taken twice daily to treat myelofibrosis…. read more

Read Article
Posted on December 5, 2011

FDA Orders Syntec Dietary Supplements Seizure

According to news sources, U.S Marshals received calls from The Food and Drug Administration to seize Syntec Inc. dietary supplement products due to false claims by the manufacturer in regards to the effectiveness of the drug to treat and cure certain diseases. The FDA announced the measure after the manufacturer reportedly introduced new products to… read more

Read Article

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields